RegBlog

RegBlog
Your daily source for regulatory news, analysis, and opinion

All Posts by Bhaven Sampat

Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges

Apr 23, 2012 Analysis

Challenges to branded drugs from generic firms have benefits and costs.

Tagged: ,

Recent Series